The complex pathway to United States Food and Drug Administration approval of Smoflipid

Journal of Parenteral and Enteral NutritionEarly View Commentary The complex pathway to United States Food and Drug Administration approval of Smoflipid Edward Tabor MD, Corresponding Author Edward Tabor MD thousandyears@comcast.net orcid.org/0000-0001-8027-675X The George Washington University School of Medicine and Health Sciences, Washington, DC, USA Correspondence Edward Tabor, MD Email: thousandyears@comcast.netSearch for more papers by...